Dr. Dinesh Khanna, (Professor of Medicine at University of Michigan, USA.), spoke about Interstitial Lung Disease (ILD) and its treatment in scleroderma at the 2024 Sclerocon conference organized by Scleroderma India.
Dr. Khanna highlighted that lung fibrosis affects 60% to 70% of scleroderma patients and emphasized the importance of early diagnosis and timely treatment. He also discussed the role of autoantibodies, the necessity of immunizations and shed light on ongoing clinical trials for…
